18 July 2018

LSIPR 50 2018: The entrepreneurial bug

Since its founding in 2000, Flagship Pioneering has set up and fostered the development of more than 100 scientific ventures, resulting in $20 billion in aggregate value, more than 500 issued patents, and more than 50 clinical trials for novel therapeutic agents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Wiggin’s new litigation partner deepens ‘technically complex’ offer

24 February 2026 The New York hire brings broad litigation and transactional experience, including advising clients on artificial intelligence, biotech, pharma and chemical matters.

Medtech

Could everyday hospital equipment be the next defence against counterfeit medicines?

23 February 2026 A new study suggests the equipment already found in hospitals worldwide could offer a front line against fake vaccines and insulin.

Americas

BioNTech fires shots at Moderna's next-generation vaccine

20 February 2026 The German biotech claims the newly approved vaccine infringes its mRNA patent, deepening an already complex feud with billions of dollars at stake.

More features

Wiggin’s new litigation partner deepens ‘technically complex’ offer

BioNTech fires shots at Moderna's next-generation vaccine

Mintz gains ex-Winston & Strawn partner and ITC expert

Abbott unit defends European protection for heart valve ‘cuff’ design

Natera targets ex-employee over mass file download before rival move

Generic rival blocked as AZ defends diabetes stronghold

Emotional Perception exclusive: ‘We are now very much open for business’

New rankings recognise top US patent firms and lawyers

LSIPR 50 2018: The entrepreneurial bug

More on this story

Editor's picks

Editor's picks

More features